arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

TELA Bio, Inc.

TELA

$0.84 ▼ -0.02 (-2.30%) at close

10 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

TELA Bio, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $39.4M

Dividend Yield —

Revenue Growth 15.8% ↘

Op. Margin -42.0% ↗

ROIC -54.8% ↘

FCF / Share $-0.61 ↗

Trailing P/E —

Price / Book 5.9x

FCF Yield —

Debt / Equity 8.82

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$80.28M

↑ +15.8% —

Net Income Profit after all expenses

$-38.83M

↓ -2.6% —

Operating Margin Operating profit as % of sales

-42.0%

↑ +14.6% 6th

FCF / Share Free cash flow per share

$-0.61

↑ +59.1% —

Long-Term Debt Long-term obligations

$55.65M

↑ +35.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	15.8% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+98%)	18.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+132%)	41.1% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+414%)	40.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+407%)	61.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+672%)	17.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+124%)	86.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+984%)	94.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1086%)	—	—
EPS Growth YoY (%)	37.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	34.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-18.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-3.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-2.6% Weak ↑ Weak Improving Year-over-year change in net income	18.9% Good ↑ Good Improving Year-over-year change in net income	-5.3% Weak ↑ Weak Improving Year-over-year change in net income	-33.1% Weak ↓ Weak Declining Year-over-year change in net income	-15.6% Weak ↓ Weak Declining Year-over-year change in net income	-28.4% Weak ↓ Weak Declining Year-over-year change in net income	-6.3% Weak Weak Year-over-year change in net income	1.1% Caution Caution Year-over-year change in net income	—	—
FCF Growth YoY (%)	59.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	17.7% Good ↑ Good Improving Year-over-year change in free cash flow	29.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-19.2% Weak Weak Year-over-year change in free cash flow	-12.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	24.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	33.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	47.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	38.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	52.7% Excellent Excellent Compound annual revenue growth over 3 years	62.5% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	34.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	35.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	47.8% Excellent Excellent Compound annual revenue growth over 5 years	57.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	-42.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-380%)	-49.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-428%)	-75.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-603%)	-94.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-728%)	-100.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-766%)	-138.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1025%)	-124.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-927%)	-214.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1533%)	-398.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2758%)	—
Effective Tax Rate (%) (%)	-0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-48.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-503%)	-54.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-555%)	-79.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-765%)	-106.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-991%)	-112.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1041%)	-158.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1417%)	-145.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1310%)	-254.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2224%)	—	—
FCF Margin (%) (%)	-35.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-61.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-70.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-100.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-105.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-135.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-166.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-241.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-388.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-54.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-48.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-58.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	12.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-41.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-47.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-65.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	—	-133.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-986%)	-247.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1748%)	—	-165.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1204%)	-58.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-492%)	-72.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-583%)	15.3% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	19.7% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+31%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	8.82x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1369%)	1.45x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+141%)	2.15x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+258%)	2.79x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+365%)	1.57x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+161%)	0.63x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.98x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+63%)	—	—	—
Interest Coverage (x)	-7.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.87x Weak Weak Operating income divided by interest expense Optimal: > 5x	-3.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$4.81M	$-11.55M	$-6.21M	$-2.10M	$-12.44M	$-43.57M	$-15.06M	$-17.28M	—	—
Debt / EBITDA (x)	-1.68x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.23x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.03x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.08x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.23x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.60x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$1.71	$2.43	$2.56	$2.55	$2.04	$1.41	—	—	—	—
Basic EPS, GAAP (USD)	$-0.83	$-1.33	$-2.04	$-2.72	$-2.30	$-2.23	—	—	—	—
Free Cash Flow per Share (USD)	$-0.61	$-1.49	$-1.81	$-2.56	$-2.15	$-1.90	—	—	—	—
Book Value per Share (USD)	$0.14	$0.72	$0.77	$0.75	$1.38	$3.40	$2.71	$-466.19	—	—
Tangible Book Value per Share (USD)	$0.11	$0.68	$0.68	$0.62	$1.22	$3.22	$2.46	$-466.19	—	—
Basic Weighted Avg Shares (shares)	46.95M	28.53M	22.87M	16.27M	14.47M	12.93M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$57.61M	$62.47M	$54.76M	$50.04M	$48.48M	$76.62M	$57.62M	$13.70M	—	—
LT Debt (USD)	$55.65M	$41.12M	$40.52M	$39.92M	$31.49M	$30.83M	$30.24M	—	—	—
Total Equity (USD)	$6.31M	$28.46M	$18.88M	$14.30M	$20.10M	$49.03M	$30.96M	$-137.86M	$-108.17M	$-81.17M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$80.28M	$69.30M	$58.45M	$41.42M	$29.46M	$18.21M	$15.45M	$8.27M	$4.25M	—
Depreciation Expense (USD)	$630.00K	$632.00K	$428.00K	$383.00K	$231.00K	$221.00K	$278.00K	$463.00K	$761.00K	—
Net Income, GAAP (USD)	$-38.83M	$-37.84M	$-46.66M	$-44.30M	$-33.28M	$-28.79M	$-22.43M	$-21.09M	$-21.33M	—
Operating Cash Flow (USD)	$-28.22M	$-41.59M	$-40.86M	$-40.75M	$-30.43M	$-24.46M	$-25.52M	$-19.92M	$-16.37M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters

TELA Bio, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TELA with peers